Trial intelligence / Profile preview

Exercise vs Niaspan in CAD with Low HDL

NCT00298909Phase 4Completed

Sponsor
Leipzig University
Start
Mar 2006
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of niacin in coronary artery disease (CAD), hypolipoproteinemia, sponsored by Leipzig University. Started Mar 2006; status: completed.

02

Drugs

niacin
03

Conditions

coronary artery disease (CAD)hypolipoproteinemia

Beyond the preview

Go deeper on NCT00298909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00298909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call